Clinical comparative study: Efficacy and tolerability of tolperisone and thiocolchicoside in acute low back pain and spinal muscle spasticity

Asian Spine Journal

Volumn 6, Issue 2, 2012, Pages 115-122

  Rao, Rajeev ^a   Panghate, Atul ^b   Chandanwale, Ajay ^c   Sardar, Indrajeet ^d   Ghosh, Mriganka ^e   Roy, Modan ^f   Banerjee, Bireswar ^e   Goswami, Ankur ^g   Kotwal, Prakash P ^g  

^a Jubilee Mission Medical College   (India)

^b Sanjeevani Hospital   (India)

^c SIR J J GROUP OF HOSPITALS   (India)

^d Nightingale Hospital   (India)

^e Department of Orthopedics   (India)

^f MEDICAL COLLEGE AND HOSPITAL   (India)

^g ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Low back pain; Muscle; Skeletal muscle relaxant; Spasm; Thiocolchicoside; Tolperisone

Indexed keywords

EID: 84865354018     PISSN: 19761902     EISSN: 19767846     Source Type: Journal    
DOI: 10.4184/asj.2012.6.2.115     Document Type: Article

References (13)

1. Cabitza P, Randelli P. Efficacy and safety of eperisone in patients with low back pain: a double blind randomized study. Eur Rev Med Pharmacol Sci 2008;12:229-35.
2. Pratzel HG, Alken RG, Ramm S. Efficacy and tolerance of repeated oral doses of tolperisone hydrochloride in the treatment of painful reflex muscle spasm: results of a prospective placebo-controlled double-blind trial. Pain 1996;67:417-25.
3. Quasthoff S, Möckel C, Zieglgänsberger W, Schreibmayer W. Tolperisone: a typical representative of a class of centrally acting muscle relaxants with less sedative side effects. CNS Neurosci Ther 2008;14:107-19.
4. Dulin J, Kovács L, Ramm S, Horvath F, Ebeling L, Kohnen R. Evaluation of sedative effects of single and repeated doses of 50 mg and 150 mg tolperisone hydrochloride. Results of a prospective, randomized, double-blind, placebo-controlled trial. Pharmacopsychiatry 1998;31:137-42.
5. Bajaj P, Arendt-Nielsen L, Madeleine P, Svensson P. Prophylactic tolperisone for post-exercise muscle soreness causes reduced isometric force: a double-blind randomized crossover control study. Eur J Pain 2003;7:407-18.
6. Koval'chuk VV, Skoromets AA, Vasil'eva IV. Comparative efficacy of different muscle relaxants in the rehabilitation of post-stroke patients with spasticity. Zh Nevrol Psikhiatr Im S S Korsakova 2008;108:14-9.
7. Stamenova P, Koytchev R, Kuhn K, et al. A randomized, double-blind, placebo-controlled study of the efficacy and safety of tolperisone in spasticity following cerebral stroke. Eur J Neurol 2005;12:453-61.
8. Stamenova P, Koytchev R, Kuhn K, et al. A randomized, double blind, placebo-controlled study of the efficacy and safety of tolperisone in spasticity following cerebral stroke. Zh Nevrol Psikhiatr Im S S Korsakova 2006;106:34-42.
9. Svensson P, Wang K, Arendt-Nielsen L. Effect of muscle relaxants on experimental jaw-muscle pain and jaw-stretch reflexes: a double-blind and placebo-controlled trial. Eur J Pain 2003;7:449-56.
10. Melka A, Tekle-Haimanot R, Lambien F. Symptomatic treatment of neurolathyrism with tolperisone HCL (Mydocalm): a randomized double blind and placebo controlled drug trial. Ethiop Med J 1997;35:77-91.
11. Soonawalla DF, Joshi N. Efficacy of thiocolchicoside in Indian patients suffering from low back pain associated with muscle spasm. J Indian Med Assoc 2008;106:331-5.
12. Ketenci A, Ozcan E, Karamursel S. Assessment of efficacy and psychomotor performances of thiocolchicoside and tizanidine in patients with acute low back pain. Int J Clin Pract 2005;59:764-70.
13. Ono H, Fukuda H, Kudo Y. Mechanisms of depressant action of muscle relaxants on spinal reflexes: participation of membrane stabilizing action. J Pharmacobiodyn 1984;7:171-6.